This content is provided for attorney education only. It does not constitute legal advice, an expert opinion, or a case-specific conclusion. Case-specific opinions require formal engagement and record review.

When attorneys and their physician experts review a pathology malpractice case, they typically start with the pathology report — the diagnosis, the microscopic findings, the staging. That is the end of the story. The pre-analytical phase is the beginning, and it is where the story most often goes wrong.

The pre-analytical phase encompasses everything that occurs from the moment a clinical order is placed through the point the specimen arrives, intact and properly preserved, at the laboratory bench. It involves clinicians, operating room staff, radiology technologists, specimen processors, and laboratory personnel — every one of whom is a potential failure point.

The Critical Statistic

Published laboratory quality literature has repeatedly identified the pre-analytical phase as the most common source of laboratory error — occurring before the pathologist is ever involved. These are not pathologist errors. They are process errors that constrain or corrupt what the pathologist sees.

What the Pre-Analytical Phase Covers

In a surgical pathology context, the pre-analytical phase includes the following audit stations:

Clinical Order and Patient Identification

Was the procedure ordered correctly and for the correct patient? Does the requisition accurately reflect the clinical indication, the specimen site, and patient identifiers? Two-identifier verification is a standard requirement at every handoff point. Failure to document it is an independently auditable deviation.

Specimen Collection

Was the specimen collected according to accepted technique for its type? For image-guided biopsies — ultrasound, CT, stereotactic — was the procedure performed on the correct target? Core needle biopsies require documentation of the number of cores obtained and the adequacy of the sample. That documentation is part of the pre-analytical record and is frequently absent or incomplete.

Labeling at the Point of Collection

Container labeling at the bedside or in the procedure suite is the single most common source of laterality errors and patient identity errors in surgical pathology. CAP standards require that containers be labeled at the time of collection in the presence of the patient, with at least two patient identifiers. When that protocol is not followed — or not documented as followed — the chain of custody is broken before the specimen leaves the room.

Litigation Relevance

A laterality labeling error — left versus right — that results in surgery on the wrong side is one of the most devastating and legally consequential pre-analytical failures. It does not require a diagnostic error. The diagnosis can be entirely correct and the wrong organ is still removed. The failure is in the label, not the microscope.

Requisition-to-Container Reconciliation

Before a specimen is accepted into the laboratory, the information on the container must be reconciled against the information on the requisition. Patient name, date of birth, specimen site, and laterality must match. If they do not, the laboratory has a documented obligation to contact the submitting clinician and resolve the discrepancy. Acceptance of a discrepant specimen without documented resolution is a pre-analytical failure.

Fixation

For most surgical pathology specimens, formalin fixation is required to preserve tissue architecture and molecular markers. Two parameters govern fixation: the fixative type must be appropriate for the intended testing, and the fixation duration must fall within established ranges. For breast specimens in particular, ASCO/CAP guidelines specify a cold ischemia time of no more than one hour and a fixation duration of 6–72 hours for accurate HER2 and hormone receptor testing. Fixation failures — too short, too long, or wrong fixative — directly compromise the validity of ancillary testing results. That compromise may not be documented in the final report.

Transport and Storage

Specimens must reach the laboratory under conditions that preserve tissue integrity. Temperature, time, and container integrity are each auditable. Fresh specimens that require frozen section or cytologic evaluation are particularly sensitive to transport delays. Documentation of transport conditions is frequently absent — and its absence is itself an auditable gap.

Why the Pre-Analytical Phase Is Frequently Unexamined in Expert Review

Many physician pathology experts appropriately focus on microscopic interpretation — the discipline central to their diagnostic practice. Gross examination, specimen processing workflows, and chain of custody systems are operationally managed by laboratory staff, Pathologists' Assistants, and processing technicians. Academic surgical pathologists, pathology directors, and laboratory medical directors may have direct operational experience in this area; many diagnostic pathologists do not. The distinction matters when the case turns on what happened before the slide.

In most pathology malpractice reviews, the focus is on microscopic interpretation: the slides, the diagnosis, the pathologist's opinion. The pre-analytical record — the requisition, the labeling documentation, the fixation logs, the chain of custody forms — is frequently not examined with the same rigor, regardless of whether it is within the retained expert's direct practice experience.

The Expert Authority Gap

Pre-analytical failures are squarely within the expertise of a PA(ASCP) with laboratory operations experience — and largely outside the direct practice experience of a diagnostic pathologist. That is not a credential limitation. It is a specificity advantage. When the case turns on what happened before the slide, the right expert is the one who has done that work for decades.

What to Look for in the Record

When evaluating a pathology case for pre-analytical failures, the following documentation should be requested and reviewed:

The absence of required documentation is itself a finding. CAP laboratory accreditation standards require that certain records be maintained. If they cannot be produced, the question becomes whether the protocol was followed at all.

How This Changes the Case

A pre-analytical failure identified in a PVA changes the structure of the case in a meaningful way. Instead of a battle between competing pathologists over microscopic interpretation — a battle where outcome is uncertain and expert credibility is everything — the attorney has a documented, objective protocol failure that is independently auditable against a written standard.

That is a fundamentally different litigation posture. And it is one that requires a reviewer who knows exactly what the standard requires, what documentation should exist, and what its absence means.

RW
Robert Weir, PA(ASCP)
Board-certified Pathologists' Assistant (PA(ASCP)) and founder of Sentinel Pathology Consulting, LLC. Robert brings 28 years of quaternary surgical pathology experience, 15 years as laboratory operations manager at two private surgical pathology laboratories, and a current academic role teaching gross surgical pathology to pathology residents.
Last updated: May 2026
Related Attorney Resources
What Is a Pathology Vulnerability Assessment? → The Pre-Analytical Phase: What Attorneys Need to Know → Diagnostic Discordance in Pathology → Request a Screening PVA →